Events Search and Views Navigation
March 2014
DIA Euro Meeting 2014
“Creating an Adaptive Pathway for Medicines to Patients–Could this Be An Approach That Fulfills the Needs of All Decision-Makers? A Roundtable Discussion.”Moderator: Andrzej Rys (European Commission, Belgium); Hans-Georg Eichler (EMA); Jurgen Windeler (IQWiG, Germany); Tomas Salmonson (CHMP/EMA); Carole Longson (NICE); Chris James (Motor Neurone Disease Association, United Kingdom); Anton Hoos (GSK).
Find out more »April 2014
Global Updates on Accelerated Access to Innovative Medicines for Patients in Need
Workshop Co-hosted by EMA, IMI, EFPIA, & MIT
Find out more »May 2014
NORD Corporate Council Meeting
“Overview of NEWDIGS-Adaptive Licensing”Thomas Unger (Pfizer).
Find out more »June 2014
Global Clinical Scholars Training Program @ Harvard Medical School
“Overview of NEWDIGS & Adaptive Licensing”Gigi Hirsch (MIT).
Find out more »DIA 2014
(1) “Adaptive, Progressive or Risk-Based Licensing Models: What Approaches Could Be Considered by Mature and Emerging Markets?”Panel Moderator: Lawrence Liberti (CISR). Hans-Georg Eichler (EMA) – An Update on International Developments. (2) “How Can Studies that Inform Relative Effectiveness Best Be Incorporated into Global Drug Development Plans?” Panel Moderator: Chris Chinn (GSK). Mark Trusheim (MIT) – Overview of the NEWDIGS Janus Initiative.
Find out more »July 2014
The Next Act
What’s Needed to Make Orphan Drugs Readily Available to People with Rare DiseasesCo-hosted by NORD, LFE and NEWDIGS
Find out more »October 2014
Centre for Innovation in Regulatory Science (CIRS)
Invited case study presentation: “NEWDIGS – What they have discovered as critical elements.”Tony Hoos (Medicines 4 Patients)
Find out more »IRGC Annual Conference 2014
Improving Risk Regulation: From Crisis Response to Learning and Innovation. “Session 2.3 – Managing Uncertainty over the Life Cycle of Drug Development and Use: Enhancing Adaptability and Flexibility in Pharmaceutical Regulation.”Ken Oye (MIT), Tony Hoos (M4P), Hans-Georg Eichler (EMA).
Find out more »TOPRA Annual Symposium 2014
“Session 5: Adaptive Licensing.”Tomas Salmonson (CHMP, MPA), Robert Hemmings (MHRA), James Anderson (GSK).
Find out more »